webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Amine-PEG3-Lys(PEG3-N3)-PEG3-N3

  CAS No.: 2244602-35-3   Cat No.: BADC-01664 4.5  

Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 is a branched linker that can be used in the synthesis of antibody-drug conjugates (ADCs).

Amine-PEG3-Lys(PEG3-N3)-PEG3-N3

Structure of 2244602-35-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C30H58N10O12
Molecular Weight
750.84

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
(2S)-2-[[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]acetyl]amino]-6-[[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]acetyl]amino]-N-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethyl]hexanamide
Canonical SMILES
C(CCNC(=O)COCCOCCOCCN=[N+]=[N-])CC(C(=O)NCCOCCOCCOCCN=[N+]=[N-])NC(=O)COCCOCCOCCN
InChI
InChI=1S/C30H58N10O12/c31-4-9-44-13-17-49-22-24-52-26-29(42)38-27(30(43)35-6-10-45-14-18-48-19-15-46-11-7-36-39-32)3-1-2-5-34-28(41)25-51-23-21-50-20-16-47-12-8-37-40-33/h27H,1-26,31H2,(H,34,41)(H,35,43)(H,38,42)/t27-/m0/s1
InChIKey
SJLHOKKVDLXMOO-MHZLTWQESA-N

Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 is a multifunctional polyethylene glycol (PEG) derivative with specific chemical functionalities, making it highly useful in various bioscience applications. Here are some key applications of Amine-PEG3-Lys(PEG3-N3)-PEG3-N3:

Bioconjugation: Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 is utilized in bioconjugation techniques to link biomolecules, such as proteins, antibodies, or DNA, to surfaces or other macromolecules. The amine group reacts with activated carboxyl groups, while the azide groups participate in click chemistry reactions. This enables the creation of stable, functional conjugates with enhanced biological activity or improved pharmacokinetics.

Drug Delivery: This PEGylated compound is used to improve the solubility, stability, and bioavailability of therapeutic agents. By conjugating drugs to Amine-PEG3-Lys(PEG3-N3)-PEG3-N3, it is possible to reduce immunogenicity and enhance circulation time in the bloodstream. This targeted delivery system can help in achieving controlled drug release and minimizing systemic side effects.

Nanoparticle Functionalization: Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 is effective in the surface modification of nanoparticles for biomedical applications. The multivalent nature of PEG allows for the attachment of multiple functional groups, improving the biocompatibility and targeting capabilities of nanoparticles. This is particularly useful for the development of diagnostic imaging agents and precision medicine.

Tissue Engineering: In tissue engineering, Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 is employed to create hydrogels and scaffolds for cell culture and tissue regeneration. The PEGylation offers a hydrophilic environment and reduces protein adsorption, promoting cell viability and growth. These hydrogels can be tailored for specific tissue types, making them vital tools in regenerative medicine.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: 20-(tert-Butoxy)-20-oxoicosanoic acid | SPDB | SC209 | DTSSP Crosslinker | Glu(OtBu)-Val-Cit-PAB-OH | 22-(tert-Butoxy)-22-oxodocosanoic acid | 1-N-Boc-3-hydroxyazetidine | C3-Amide-C4-NH2 | Boc-D-Dap(N3) CHA salt | Fmoc-N-amido-PEG4-propionic acid | Amine-PEG3-Lys(PEG3-N3)-PEG3-N3
Send Inquiry
Verification code
Inquiry Basket